Skip to content

COVID-19: We are helping to tackle vaccine hesitancy

We’re addressing vaccine hesitancy, one of the top 10 risks to global health, and are working with employers worldwide to promote vaccine uptake. 

A needle and vaccine in a vial

A vaccine is only effective in preventing a disease with appropriate public uptake.  

A quarter of Americans are hesitant about a coronavirus vaccine. 

One in six Britons say they’re unlikely to or definitely won’t get one. 

The World Health Organization listed vaccine hesitancy as one of the top ten risks to global health in 2019. Public resistance to immunisation programs is as real a threat to world health as the viruses themselves. Over the past years, we have witnessed an erosion in vaccine confidence along with a rise in strong anti-vaccine sentiment. 

Effective communication to prepare a ‘vaccine literate’ public and persuade policymakers to trust the science must begin now. We need to reinforce the critical role immunisation plays within a functioning health delivery system. 

CONVINCE Initiative 

We have drawn upon our powerful network and have convened a series of international dialogues on building public support and understanding of COVID-19 vaccines.  

Our work has led to the launch of the CONVINCE Initiative: a global communication and education initiative to promote vaccine acceptance through employers.  

Participants joining a Wilton Park virtual meeting

CONVINCE (COVID-19 New Vaccine Information, Communication, and Education) is a new initiative that will play a crucial role in the campaign to advance vaccine literacy. 

It will give employers worldwide a roadmap to promote vaccine uptake and help ensure a strong and swift recovery from the COVID-19 pandemic through widespread acceptance of safe, effective and accessible vaccines.  

We are very pleased that the private sector has taken part in our multisector dialogues and has now made this important commitment to promote COVID-19 recovery by supporting global business efforts to build vaccine literacy and support for the potentially game-changing impact of a COVID-19 vaccine.

“We need to start now to listen and engage local communities to build resilience against COVID-19 and recover as societies, schools and economies build a new future. We are thrilled to be part of this important initiative to build public confidence through CONVINCE.” 

Prof. Heidi Larson, Director of The Vaccine Confidence Project at the London School of Hygiene and Tropical Medicine 

The CONVINCE Initiative was made possible though a partnership formed at Wilton Park between the United States Council for International Business (USCIB), The USCIB Foundation, and Business Partners for Sustainable Development (BPSD). 

Event Report Call to action

 “We were pleased to contribute extensively to the Wilton Park dialogues and to highlight the potential role for employers as ‘Trusted Influencers’ as part of the CONVINCE initiative. As three of the world’s largest and most representative business organizations – we expect to engage an extensive network to help corporate employers and governments meet the intense global and local challenge of health and vaccine promotion. Together, we can mount an unprecedented response to the COVID-19 pandemic.” 

Peter Robinson, USCIB President and CEO  

 “Many people say the only way we can achieve a ’next normal’ world is with a vaccine, but it will take collective action to make this happen. We are pleased to work across sectors with business leaders, employees and customers on the innovative communication programs that are needed urgently to build the foundation of trust that can lead us towards vaccine-protected communities.” 

Dr. Scott Ratzan, executive director of BPSD and Distinguished Lecturer at CUNY SPH